As aforementioned, Stathias et al. (Stathias et al., 2018) proposed a method termed SynergySeq to screen drug pairs acting in a synergistic way, in order to combat the resistance of BET inhibitors in glioblastoma multiforme. Here, DNER is linked to glioblastoma.